{"id":"https://openalex.org/keywords/trilaciclib","display_name":"trilaciclib","description":"Trilaciclib is a cyclin-dependent kinase 4/6 inhibitor used to protect bone marrow from chemotherapy-induced myelosuppression in cancer treatment.","display_name_alternatives":["G1T28","G1T-28","Cosela"],"ids":{"openalex":"https://openalex.org/keywords/trilaciclib","wikidata":"https://www.wikidata.org/wiki/Q105592965"},"primary_topic":{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.2665,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.2665,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.2139,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.1023,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"works_count":220,"cited_by_count":2564,"works_api_url":"https://api.openalex.org/works?filter=keywords.id:keywords/trilaciclib","updated_date":"2026-11-22T04:06:09","created_date":"2026-09-30T00:00:00"}
